Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Buy at StockNews.com

StockNews.com cut shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a strong-buy rating to a buy rating in a research note published on Saturday. Other equities analysts have also issued research reports about the stock. Canaccord Genuity Group lowered shares of Vertex Pharmaceuticals from a hold rating to a sell rating and lifted their […]

Related Keywords

Ourania Tatsis ,Vertex Pharmaceuticals Incorporated ,Wells Fargo Company ,Canaccord Genuity Group ,Norges Bank ,Vanguard Group Inc ,Insider Activity At Vertex Pharmaceuticals ,Securities Exchange Commission ,Analyst Recommendations For Vertex Pharmaceuticals ,Vertex Pharmaceuticals ,Hedge Funds Weigh In On Vertex Pharmaceuticals ,Vertex Pharmaceuticals Stock Performance ,News Ratings For Vertex Pharmaceuticals Daily ,Barclays ,Capital Research Global Investors ,Vertex Pharmaceuticals Company Profile ,Jennison Associates ,Maxim Group ,Free Report ,Genuity Group ,Moderate Buy ,Get Free Report ,Exchange Commission ,World Investors ,Research Global Investors ,Pharmaceuticals Incorporated ,Vertex Pharmaceuticals Daily ,